Niche-based screening identifies small-molecule inhibitors of leukemia stem cells

被引：1

作者：

Hartwell, Kimberly A. ^{[1
,2
,3
]}

Miller, Peter G. ^{[2
,3
]}

Mukherjee, Siddhartha ^{[4
,5
]}

Kahn, Alissa R. ^{[6
]}

Stewart, Alison L. ^{[1
]}

Logan, David J. ^{[1
]}

Negri, Joseph M. ^{[1
]}

Duvet, Mildred ^{[1
,4
,5
]}

Jaeras, Marcus ^{[2
,3
]}

Puram, Rishi ^{[2
,3
]}

Dancik, Vlado ^{[1
]}

Al-Shahrour, Fatima ^{[1
,2
,3
]}

Kindler, Thomas ^{[2
,3
]}

Tothova, Zuzana ^{[2
,3
]}

Chattopadhyay, Shrikanta ^{[1
,7
]}

Hasaka, Thomas ^{[1
]}

Narayan, Rajiv ^{[1
]}

Dai, Mingji ^{[1
,8
]}

Huang, Christina ^{[1
]}

Shterental, Sebastian ^{[2
,3
]}

Chu, Lisa P. ^{[2
,3
]}

Haydu, J. Erika ^{[2
,3
]}

Shieh, Jae Hung ^{[6
]}

Steensma, David P. ^{[3
,9
]}

Munoz, Benito ^{[1
]}

Bittker, Joshua A. ^{[1
]}

Shamji, Alykhan F. ^{[1
]}

Clemons, Paul A. ^{[1
]}

Tolliday, Nicola J. ^{[1
]}

Carpenter, Anne E. ^{[1
]}

Gilliland, D. Gary ^{[1
,2
,3
,9
,10
]}

Stern, Andrew M. ^{[1
]}

Moore, Malcolm A. S. ^{[11
]}

Scadden, David T. ^{[1
,4
,5
,7
]}

Schreiber, Stuart L. ^{[1
,8
,10
]}

Ebert, Benjamin L. ^{[1
,2
,3
,9
]}

Golub, Todd R. ^{[1
,3
,10
,12
]}

机构：

[1] Broad Inst, Cambridge, MA 02142 USA

[2] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Boston, MA USA

[4] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA

[5] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

[6] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA

[7] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA

[8] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA

[9] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[10] Harvard Univ, Howard Hughes Med Inst, Sch Med, Chevy Chase, MD USA

[11] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA

[12] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA

来源：

NATURE CHEMICAL BIOLOGY | 2013年 / 9卷 / 12期

基金：

美国国家科学基金会; 美国国家卫生研究院;

关键词：

ACUTE MYELOID-LEUKEMIA; PROGENITOR CELLS; STROMAL CELLS; PROTEIN TRANSFERASE; FREQUENCY-ANALYSIS; INDUCED APOPTOSIS; IN-VIVO; CANCER; GENES; MICE;

D O I：

10.1038/NCHEMBIO.1367

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Efforts to develop more effective therapies for acute leukemia may benefit from high-throughput screening systems that reflect the complex physiology of the disease, including leukemia stem cells (LSCs) and supportive interactions with the bone marrow microenvironment. The therapeutic targeting of LSCs is challenging because LSCs are highly similar to normal hematopoietic stem and progenitor cells (HSPCs) and are protected by stromal cells in vivo. We screened 14,718 compounds in a leukemia-stroma co-culture system for inhibition of cobblestone formation, a cellular behavior associated with stem-cell function. Among those compounds that inhibited malignant cells but spared HSPCs was the cholesterol-lowering drug lovastatin. Lovastatin showed anti-LSC activity in vitro and in an in vivo bone marrow transplantation model. Mechanistic studies demonstrated that the effect was on target, via inhibition of HMG-CoA reductase. These results illustrate the power of merging physiologically relevant models with high-throughput screening.

引用

页码：840 / +

页数：12

共 50 条

[31] Small-Molecule Inhibitors of the Proteasome's Regulatory Particle
Muli, Christine S.
Tian, Wenzhi
Trader, Darci J.
CHEMBIOCHEM, 2019, 20 (14) : 1739 - 1753
[32] FDA-approved small-molecule kinase inhibitors
Wu, Peng
Nielsen, Thomas E.
Clausen, Mads H.
TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (07) : 422 - 439
[33] Synthetic Lethal Screening with Small-Molecule Inhibitors Provides a Pathway to Rational Combination Therapies for Melanoma
Roller, Devin G.
Axelrod, Mark
Capaldo, Brian J.
Jensen, Karin
Mackey, Aaron
Weber, Michael J.
Gioeli, Daniel
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (11) : 2505 - 2515
[34] Targeting the transcription factor Myb by small-molecule inhibitors
Uttarkar, Sagar
Frarnpton, Jon
Klempnauer, Karl-Heinz
EXPERIMENTAL HEMATOLOGY, 2017, 47 : 31 - 35
[35] Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells
Fukushima, Nobuaki
Minami, Yosuke
Kakiuchi, Seiji
Kuwatsuka, Yachiyo
Hayakawa, Fumihiko
Jamieson, Catoriona
Kiyoi, Hitoshi
Naoe, Tomoki
CANCER SCIENCE, 2016, 107 (10) : 1422 - 1429
[36] Cellular Proliferation and Migration of Human Pterygium Cells: Mitomycin Versus Small-Molecule Inhibitors
Cao, Di
Chu, Wai Kit
Ng, Tsz Kin
Yip, Yolanda W. Y.
Young, Alvin L.
Pang, Chi Pui
Jhanji, Vishal
CORNEA, 2018, 37 (06) : 760 - 766
[37] Mechanism of action for small-molecule inhibitors of triacylglycerol synthesis
Sui, Xuewu
Wang, Kun
Song, Kangkang
Xu, Chen
Song, Jiunn
Lee, Chia-Wei
Liao, Maofu
Farese, Robert V., Jr.
Walther, Tobias C.
NATURE COMMUNICATIONS, 2023, 14 (01)
[38] Advances in Small-Molecule Inhibitors of Protein Tyrosine Kinases
Wang, Yong
Long, Yaqiu
CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2011, 31 (10) : 1595 - 1606
[39] Cardiotoxicity of small-molecule kinase inhibitors in cancer therapy
Shuangli Zhu
Kai Fu
Sijia Li
Chuan Yang
Can Pan
Xueping Wang
Fang Wang
Xiyong Yu
Kenneth Kin Wah To
Liwu Fu
Experimental Hematology & Oncology, 14 (1)
[40] Cell-Based Small-Molecule Compound Screen Identifies Fenretinide as Potential Therapeutic for Translocation-Positive Rhabdomyosarcoma
Martin, David Herrero
Boro, Aleksandar
Schaefer, Beat W.
PLOS ONE, 2013, 8 (01):

← 1 2 3 4 5 →